Metronidazole (flagyl), a radiosensitiser of possible clinical use in cancer chemotherapy: Some biochemical and pharmacological considerations
- 15 May 1976
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 25 (10) , 1151-1156
- https://doi.org/10.1016/0006-2952(76)90362-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Phase 1 Study of High-Dose Metronidazole: A SpecificIn VivoandIn VitroRadiosensitizer of Hypoxic CellsRadiology, 1975
- In vivotesting of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony techniqueThe British Journal of Radiology, 1975
- Tumor and Normal Tissue Response to Metronidazole and Irradiation in MiceRadiology, 1974
- Metronidazole (“Flagyl”). A radiosensitizer of hypoxic cellsThe British Journal of Radiology, 1974
- Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazoleThe British Journal of Radiology, 1974
- “High-dose” metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trialsThe British Journal of Radiology, 1974
- Effectiveness of nitrofuran derivatives in sensitizing hypoxic mammalian cells to X raysThe British Journal of Radiology, 1973
- Radiosensitization of anoxic cells by metronidazoleThe British Journal of Radiology, 1973
- Sensitization of Anoxic Bacteria to X-rays by Di-t-butyl Nitroxide and AnaloguesNature, 1964
- HIGH-PRESSURE OXYGEN AND RADIOTHERAPYThe Lancet, 1955